Los Angeles, CA - 
(NewMediaWire) - October 6, 2021 - The Schall Law Firm, a
national shareholder rights litigation firm, announces that it is investigating
claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. (“Ginkgo” or “the Company”) (NYSE: DNA)
for violations of the securities laws.
The investigation focuses on
whether the Company issued false and/or misleading statements and/or failed to
disclose information pertinent to investors. Ginkgo is the subject of a report
published by Scorpion Capital on October 6, 2021. The report alleges that the
Company is a “colossal scam.” The report describes the Company as a “shell
game” whose revenues are highly dependent on related-party transactions.
Scorpion Capital alleges that the Company is a “Frankenstein mash-up of the
worst frauds of the last 20 years.” Based on this news, Ginkgo shares fell as
much as 20% in intraday trading on the same day.
If you are a shareholder who
suffered a loss, click here to participate.
We also encourage you to contact
Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los
Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You
can also reach us through the firm's website at www.schallfirm.com,
or by email at brian@schallfirm.com.
The class in this case has not
yet been certified, and until certification occurs, you are not represented by
an attorney. If you choose to take no action, you can remain an absent class
member.
The Schall Law Firm represents
investors around the world and specializes in securities class action lawsuits
and shareholder rights litigation.
This press release may be
considered Attorney Advertising in some jurisdictions under the applicable law
and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
